Investigation Report on China Capecitabine Market, 2010-2019

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over …
Reference: 1506203
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/11/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer has mainly relied on traditional cytotoxic drugs for years. Capecitabine, as orally-administered tablets, acts directly in intestine and drug concentration in the tumor tissues is higher than that in blood. Besides, it features flexible dose adjustments and compliant method of administration. All this has contributed to its market growth.
Capecitabine develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 635 million in 2014 and CAGR reaching up to 25.3% during this period. Capecitabine enjoys a vast demand in China. Currently, there are mainly five manufacturers of capecitabine in China: Shanghai Roche Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd, among which Shanghai Roche Pharmaceutical Co., Ltd has the largest market share of over 95% with sales value exceeding CNY 600 million in 2014.
With the degradation of environment and lifestyle changes brought about by improved living standards, the incidence of cancer keeps increasing in China. Therefore, capecitabine has good prospects in China and its market size will keep growing.

Readers can get at least the following information from this report:
-market share of manufacturers of capecitabine in China
-price of capecitabine in Chinese market
-major manufacturers of capecitabine in Chinese market
-share of dosage forms of capecitabine in China
-market outlook of capecitabine in China

The author suggests the following groups of people purchase this report:
-manufacturers of antitumor drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Contents

1 Related Concepts of Capecitabine
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Capecitabine in China
2.1 Patent and Approval Status of Capecitabine in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Capecitabine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Capecitabine in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Capecitabine in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Capecitabine in Chinese Hospitals in 2014
6.1 Shanghai Roche Pharmaceutical Co., Ltd (Trade Name: Xeloda)
6.2 Qilu Pharmaceutical Co., Ltd (Trade Name: Zhuo Lun)
6.3 Jiangsu Hengrui Medicine Co., Ltd (Trade Name: Ai Bin)
6.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd

7 Major Manufacturers of Capecitabine in Chinese Market, 2010-2014
7.1 Qilu Pharmaceutical Co., Ltd
7.2 Shanghai Roche Pharmaceutical Co., Ltd
7.3 Jiangsu Hengrui Medicine Co., Ltd
7.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd

8 Market Outlook of Capecitabine in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Table of Charts
Chart Patent Status of Capecitabine in China
Chart Patent and Approval Status of Capecitabine in China
Chart Sales Status of Capecitabine in China, 2010-2014
Chart Sales Value of Capecitabine in China, 2010-2014
Chart Sales Value of Capecitabine in Some Regions in China, 2010-2014
Chart Sales Volume of Capecitabine in China, 2010-2014
Chart Sales Volume of Capecitabine in Some Regions in China, 2010-2014
Chart Market Share of TOP4 Manufacturers of Capecitabine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Capecitabine Made by Shanghai Roche in China, 2010-2014
Chart Sales Value and Market Share of Capecitabine Made by Chia Tai Tianqing in China, 2010-2014
Chart Sales Value and Market Share of Capecitabine Made by Jiangsu Hengrui in China, 2010-2014
Chart Sales Value and Market Share of Capecitabine Made by Qilu Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Capecitabine Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Capecitabine in China, 2010-2014
Chart Price of Capecitabine Made by Shanghai Roche Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Capecitabine Made by Qilu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Capecitabine Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
Chart Price of Capecitabine Made by Jiangsu Aosaikang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Scroll